» Authors » Hiroaki Mitsugashira

Hiroaki Mitsugashira

Explore the profile of Hiroaki Mitsugashira including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 15
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Korekawa K, Mitsugashira H, Yashima Y, Asakura T
Intern Med . 2024 Oct; PMID: 39401913
A 70-year-old man with diabetes was treated with a sodium glucose cotransporter 2 (SGLT2) inhibitor. He developed vomiting and epigastric pain and was diagnosed with diabetic ketoacidosis (DKA). Computed tomography...
2.
Saito R, Inagaki A, Nakamura Y, Imura T, Kanai N, Mitsugashira H, et al.
Cell Transplant . 2024 May; 33:9636897241251621. PMID: 38756050
Subcutaneous islet transplantation is a promising treatment for severe diabetes; however, poor engraftment hinders its prevalence. We previously revealed that a gelatin hydrogel nonwoven fabric (GHNF) markedly improved subcutaneous islet...
3.
Saito R, Inagaki A, Nakamura Y, Imura T, Kanai N, Mitsugashira H, et al.
Cells . 2024 Jan; 13(1). PMID: 38201255
Although subcutaneous islet transplantation has many advantages, the subcutaneous space is poor in vessels and transplant efficiency is still low in animal models, except in mice. Subcutaneous islet transplantation using...
4.
Ishikawa Y, Saito R, Murakami K, Fujio A, Miyazawa K, Sasaki K, et al.
Tohoku J Exp Med . 2023 Sep; 261(4):267-272. PMID: 37766552
Biliary atresia is an obliterative cholangiopathy of unknown etiology. Hepatic portoenterostomy, in which obliterated extrahepatic bile ducts are resected and bile flow is restored, known as Kasai operation, is performed...
5.
Kanai N, Inagaki A, Nakamura Y, Imura T, Mitsugashira H, Saito R, et al.
Sci Rep . 2023 Jul; 13(1):11968. PMID: 37488155
Subcutaneous islet transplantation is a promising treatment for severe diabetes; however, poor engraftment hinders its prevalence. We previously reported that a recombinant peptide (RCP) enhances subcutaneous islet engraftment. However, it...
6.
Takido N, Saito R, Okada K, Kanai N, Shono Y, Mitsugashira H, et al.
Tohoku J Exp Med . 2023 Jul; 261(1):75-81. PMID: 37468258
Tumor-to-tumor metastasis is a rare phenomenon in which primary tumor cells metastasize to other tumors. Herein, we report an extremely rare case of tumor-to-tumor metastasis of medullary thyroid carcinoma to...
7.
Saito R, Inagaki A, Nakamura Y, Imura T, Kanai N, Mitsugashira H, et al.
Cell Transplant . 2023 Jul; 32:9636897231186063. PMID: 37466120
Subcutaneous islet transplantation is a promising treatment for severe diabetes; however, poor engraftment hinders its prevalence. We previously revealed that a gelatin hydrogel nonwoven fabric (GHNF) markedly improved subcutaneous islet...
8.
Yamana H, Tokodai K, Fujio A, Kashiwadate T, Miyazawa K, Sasaki K, et al.
Transplant Proc . 2023 May; 55(4):930-933. PMID: 37127515
Background: After pediatric liver transplantation, liver fibrosis may occur during long-term follow-up. Noninvasive markers for assessing this liver fibrosis are desired. Mac-2 binding protein glycosylated isomer (M2BPGi) has recently been...
9.
Mitsugashira H, Imura T, Inagaki A, Endo Y, Katano T, Saito R, et al.
Sci Rep . 2022 Aug; 12(1):14731. PMID: 36042259
Subcutaneous tissue is a promising site for islet transplantation, but poor engraftment, due to hypoxia and low vascularity, hinders its prevalence. However, oxygen partial pressure (pO) of the subcutaneous space...
10.
Mitsugashira H, Tokodai K, Nakanishi W, Fujio A, Kashiwadate T, Miyazawa K, et al.
Transplant Proc . 2022 Jan; 54(2):230-232. PMID: 35031119
Background: The number of brain-dead donors has been increasing; however, the opportunity for young surgeons to experience deceased donor surgeries is extremely limited, especially in many Asian countries including Japan....